Prescription drug · ANDA
Itraconazole Oral (itraconazole) NDC 69339-159
Itraconazole 10 mg/mL · Solution · Oral · Natco Pharma USA LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 69339-159-17 | 69339015917 | 40 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (69339-159-17) / 10 mL in 1 CUP, UNIT-DOSE (69339-159-01)Marketed from Apr 25, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Itraconazole Oral
- Generic name (nonproprietary)
- itraconazole
- Active ingredients
- Itraconazole — 10 mg/mL
- Dosage form
- Solution
- Route
- Oral
- Labeler
- Natco Pharma USA LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 212239
- Marketing start
- Listing expires
- Other FDA classes
- Azoles (Chemical structure)Breast Cancer Resistance Protein Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
- Identifiers
- Product ID 69339-159_2af07b39-fe93-4961-90cb-ed9c5e2f424dSPL ID 2af07b39-fe93-4961-90cb-ed9c5e2f424dSPL set ID da63870d-b426-4e49-9591-5bb51f962e66RxCUI 348506UNII 304NUG5GF4UPC 0369339159019
- Pharmacologic class
- Azole Antifungal
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N469339015917followed by a unit qualifier and the quantityPackage 69339-0159-17. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Itraconazole oral solution is indicated for the treatment of oropharyngeal and esophageal candidiasis. (See CLINICAL PHARMACOLOGY: Special Populations , WARNINGS , and ADVERSE REACTIONS: Post-marketing Experience for more information .)
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 212239
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Itraconazole | Itraconazole 10 mg/mL | SolutionOral | Camber Pharmaceuticals, Inc. | 31722-006 |
- openFDA data updated
Med-Code stores this record for up to 24 hours before requesting it again.
Reference information only. Verify codes and billing rules against the applicable payer and official source before submitting a claim. How Med-Code handles data.